Skip to Main Content

Paper Details

Response to bipolar androgen therapy and PD-1 inhibition in a patient with metastatic castration-resistant prostate cancer and a germline <i>CHEK2</i> mutation.
BMJ Case Rep
1
2023
Author NameAffiliation
Emmanuel S AntonarakisUniversity of Minnesota Academic Health Center
  • 1 - 1

Datasets

Release 1.2